Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Lysosomal enzymes, processing

Post-translational processing defect Trafficking defects of lysosomal enzymes... [Pg.688]

A. Ilasilik, The Early and Late Processing of Lysosomal Enzymes Proteolysis and Compartimentation , Experientia 1992, 48, 130-151. [Pg.60]

Oxidized LDL alter cellular functions role in cell death Oxidized LDL seem to be poorly degraded by lysosomal enzymes and accumulate in lysosomes altering in turn their functionality (Dean et al., 1997). It has been proposed that inhibition of oxidized LDL degradation and subsequent lipid accumulation may induce a destabilization of the acidic compartment, and lysosomal rupture with a relocation of lysosomal enzymes in the cytosol (li W et al, 1998). This process, also called endopepsis , occurs early and could precede mitochondrial dysfunction and cell death (Lossel et al., 1994). Moreover, oxidized LDL trigger a dysfunction of the intracellular proteolytic ubiquitin/proteasome pathway (early activation followed by inhibition)... [Pg.137]

Mecfianism of Action A corticosteroid that inhibits accumulation of inflammatory cells at inflammation sites, phagocytosis, lysosomal enzyme release, and synthesiser release of mediators of inflammation. Therapeutic Effect Decreases or prevents tissue response to inflammatory process. [Pg.280]

Mechanism of Action A long-acting glucocorticoid that inhibits accumulation of inflammatory cells at inflammation sites, phagocytosis, lysosomal enzyme release and synthesis, and releaseof mediators of inflammation. Therapeutic Effect Prevents and suppresses cell and tissue immune reactions and inflammatory process. Pharmacohinetics Rapidly, completely absorbed from the G1 tract after oral administration. Widely distributed. Protein binding High. Metabolized in the liver. Primarily excreted in urine. Minimally removed by hemodialysis. Half-life 3-4.5 hr. [Pg.344]

Fig. I. Endocytic pathways used by cells to internalize soluble macromolecules [25] fluid-phase pinocytosis (1), adsorptive pinocytosis (2), and receptor-mediated endocytosis (pinocytosis) (6). Each of these processes involves a formation of a sealed vesicle formed from the plasma membrane which encloses part of the extracellular medium. The internalization of a polymer-drug conjugate (P-D), and targeted polymer-drug conjugate ( => —P-D) is shown. Other abbreviations — = cell surface receptor/antigen 1 = clathrin molecule X = lysosomal enzyme. Fluid-phase pinocytosis (1) and adsorptive pinocytosis (2) are nonspecific processes which direct the macromolecule into the lysosomal compartment of the cell. Once P-D is internalized, whether by (1) or (2), the resulting endosome (3) is ultimately fused with a primary lysosome (4) forming a secondary lysosome (5). In the latter compartment P-D is in contact with several types of lysosomal enzymes. The membrane of (5) is impermeable to macromolecules. Consequently, the structure of P-D may be designed in such... Fig. I. Endocytic pathways used by cells to internalize soluble macromolecules [25] fluid-phase pinocytosis (1), adsorptive pinocytosis (2), and receptor-mediated endocytosis (pinocytosis) (6). Each of these processes involves a formation of a sealed vesicle formed from the plasma membrane which encloses part of the extracellular medium. The internalization of a polymer-drug conjugate (P-D), and targeted polymer-drug conjugate ( => —P-D) is shown. Other abbreviations — = cell surface receptor/antigen 1 = clathrin molecule X = lysosomal enzyme. Fluid-phase pinocytosis (1) and adsorptive pinocytosis (2) are nonspecific processes which direct the macromolecule into the lysosomal compartment of the cell. Once P-D is internalized, whether by (1) or (2), the resulting endosome (3) is ultimately fused with a primary lysosome (4) forming a secondary lysosome (5). In the latter compartment P-D is in contact with several types of lysosomal enzymes. The membrane of (5) is impermeable to macromolecules. Consequently, the structure of P-D may be designed in such...
Hyal-1, an acid-active lysosomal enzyme, was the first somatic hyaluronidase to be isolated and characterized.191,192 It is a 57 kDa single polypeptide glycoprotein that also occurs in a processed 45 kDa form, the result of two endoprotease reactions. The resulting two chains are bound by disulfide bonds. This is not a zymogen-active enzyme relationship, since the two isoforms have similar specific activities. Why two forms should occur is unknown. Only the larger form is present in the circulation, while both isoforms occur in urine,193 in tissue extracts, and in cultured cells. Why an acid-active hyaluronidase should occur in plasma is not clear. Some species do not have detectable enzymatic activity in their circulation,194 but an inactive 70 kDa precursor form of the enzyme is present in such sera, detectable by Western blot (L. Shifrin, M. Neeman, and R. Stern, unpubl. data). Hyal-1 is able to utilize HA of any size as substrate, and generates predominantly tetrasaccharides. [Pg.259]

The lysosomal enzymes The lysosomes are membrane vesicles ubiquitous to mammalian cells and contain a panoply of hydrolytic enzymes, estimated to be over 60 in number, that function to digest practically any biological macromolecule. They are important to the discussion of oral macromolecular drug delivery for two reasons. First, any macromolecules that escape digestion by the pancreatic and brush border enzymes are likely to be taken up into the epithelial cells by the process of endocytosis. In this process, the apical membrane invaginates and the target molecules enter endocytic vesicles that then fuse with the lysosomes and are subjected to intracellular hydrolysis by the lysosomal enzymes. Second, the sloughing-off of the epithelial cells means that the lysosomal enzymes will be released into the lumen of the intestine. They may be... [Pg.11]

Historically, the important observation made by Hickman and Neufeld (1972) that I-cell fibroblasts are capable of endocytosing (the process by which cells take up macromolecules) lysosomal enzymes secreted by normal cells but that normal cells are incapable of internalizing the enzymes secreted by I-cell fibroblasts suggested that some kind of recognition marker for internalization of lysosomal enzymes was absent in I-cell fibroblasts. This recognition marker has subsequently been identified as mannose 6-phosphate. [Pg.186]


See other pages where Lysosomal enzymes, processing is mentioned: [Pg.96]    [Pg.96]    [Pg.127]    [Pg.558]    [Pg.250]    [Pg.649]    [Pg.688]    [Pg.54]    [Pg.12]    [Pg.100]    [Pg.104]    [Pg.205]    [Pg.252]    [Pg.436]    [Pg.61]    [Pg.363]    [Pg.813]    [Pg.67]    [Pg.69]    [Pg.167]    [Pg.208]    [Pg.240]    [Pg.297]    [Pg.996]    [Pg.1157]    [Pg.23]    [Pg.838]    [Pg.178]    [Pg.4]    [Pg.253]    [Pg.237]    [Pg.339]    [Pg.426]    [Pg.187]    [Pg.190]    [Pg.191]   
See also in sourсe #XX -- [ Pg.316 ]




SEARCH



Enzyme processes

Enzyme processive

Lysosomal

Lysosomal enzymes

Lysosome Lysosomal enzymes

Lysosome enzymes

Lysosomes

Lysosomic enzymes

© 2024 chempedia.info